# IVRA
> **NDA217110** · New Drug Application · Sponsor: APOTEX · Approved 2023-08-18
## Drug
- **FDA Application Number:** NDA217110
- **Application type:** New Drug Application
- **Brand name:** IVRA
- **Generic name:** MELPHALAN HCL
- **Active ingredients:** MELPHALAN HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** APOTEX
- **Manufacturer:** Apotex Corp
- **First approval:** 2023-08-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217110)
---
*AI Analytics · CC0 1.0*